Market Herald logo

Subscribe

Be the first with the news that moves the market
  • FinCanna Capital Corp. (CALI) has received approval to amend its outstanding convertible debentures
  • The maturity date of the debentures has been extended by 12 months
  • The conversion price has been reduced from $0.15 to $0.005 per share impacting 55 per cent of the currently outstanding debentures
  • The company also expects to be placed on inactive status by the Canadian Securities Exchange, with the company’s trading symbol changing to “CALI.X”
  • FinCanna Capital Corp. was an investment company providing growth capital to rapidly emerging private companies operating in the licensed U.S cannabis industry
  • FinCanna Capital Corp. (CALI) remained unchanged at $0.005 at 11:17 ET

FinCanna Capital Corp. (CALI) has received debenture holder approval to amend its outstanding convertible debentures.

The first part of the amendment is the extension of the maturity date by 12 months. The second part is the reduction of the conversion price from $0.15 to $0.005 per share and the conversion of a total of 55 per cent of the currently outstanding debentures.

The third is to allow for up to two more consecutive quarters of interest payments under the convertible debentures to be satisfied by issuing common shares. A third (or more) consecutive quarter of satisfying interest payments with common shares of the company will require further debenture holder approval and is subject to the approval of the Canadian Securities Exchange.

The company previously issued convertible debentures, as amended from time to time, in February 2019 and July 2020. The convertible debentures, as amended, mature on January 10, 2024, and February 8, 2024, respectively, and bear annual interest at 12 per cent.

The company has also disclosed that it expects to be placed on inactive status by the Canadian Securities Exchange, with the company’s trading symbol changing to “CALI.X”.

FinCanna Capital Corp. was an investment company providing growth capital to rapidly emerging private companies operating in the licensed U.S. cannabis industry. Currently, the company does not have active business operations.

FinCanna Capital Corp. (CALI) remained unchanged at $0.005 at 11:17 ET.


More From The Market Herald

" Innocan Pharma (CSE:INNO) reports successful efficacy test for vaginal derma product

Innocan Pharma (INNO) has announced successful results from a controlled efficacy test of its vaginal derma product.

" @ the Bell: TSX bounces back again

Euro banking drama had a ripple effect felt on Bay Street Friday but Canada’s main stock index dodged another close in the red.
RBC

" Survey shows fraud risk a rising concern for Canadians

Latest survey by Royal Bank of Canada shows Canadians are concerned about spotting scams and that fraud risk will get worse if a recession

" A.I.S. Resources (TSXV:AIS) updates on its Argentina properties

A.I.S. Resources has provided an update to its Pocitos properties in the Salta, Argentina region.